Intravenous ferric derisomaltose in iron-deficient patients undergoing transcatheter aortic valve implantation due to severe aortic stenosis: study protocol of the randomised controlled IIISAS trial.
Sara BardanAnette Borger KvaslerudKristoffer AndresenSophie Foss KløveThor EdvardsenLars GullestadKaspar BrochPublished in: BMJ open (2022)
NCT04206228.
Keyphrases
- study protocol
- transcatheter aortic valve implantation
- aortic stenosis
- patients undergoing
- iron deficiency
- transcatheter aortic valve replacement
- aortic valve replacement
- ejection fraction
- aortic valve
- randomized controlled trial
- left ventricular
- clinical trial
- coronary artery disease
- high dose
- open label
- early onset
- placebo controlled
- double blind
- phase iii
- heart failure
- drug induced
- phase ii